We develop (non-coding) RNA therapeutics for incurable diseases using genomics and bioinformatics.
PI: Rory Johnson
Our mission is to develop better therapies for common diseases through understanding the original molecule of Life: RNA.
We develop tools based on CRISPR-Cas genome-editing and bioinformatics to discover and drug disease-causing RNAs.
We focus on the important yet mysterious class of long noncoding RNAs (lncRNAs).
We are an interdisciplinary, international research group based at University College Dublin.